Thomas Roddy

Thomas Roddy's work experience is as follows:

- Senior VP of Platform at Atavistik Bio since March 2022 (ongoing)

- Senior VP of Metabolism and Protein Sciences at Atavistik Bio from July 2021 to March 2022

- VP of Metabolism and Proteomics and External Innovation Lead at Agios Pharmaceuticals from January 2020 to July 2021

- Sr Director of Metabolism at Agios Pharmaceuticals from January 2015 to January 2020

- VP Drug Discovery at Beryllium from February 2014 to January 2015

- Director of Analytical Biochemistry in Molecular Biomarkers at Merck from September 2011 to December 2013

- Exploratory Biomarkers Team Leader, Atherosclerosis at Merck from August 2008 to September 2011

- Staff Scientist at Genzyme from June 2007 to August 2008

- Lab Head, Analytical Chemistry at Novartis Institutes for Biomedical Research from 2004 to June 2007

- Scientist at Genzyme from 2002 to 2004.

Thomas Roddy earned their Bachelor of Science degree in Chemistry from Juniata College, which they attended from 1991 to 1995. Thomas then pursued a Master of Science degree in Chemistry at Villanova University between 1995 and 1997. Thomas Roddy continued their education at Penn State University, where they obtained their PhD in Chemistry from 1997 to 2002.